Ulf Meier-Kriesche
Chief Tech/Sci/R&D Officer at VELOXIS PHARMACEUTICALS A/S
Profile
Ulf Meier-Kriesche is currently the Chief Scientific Officer at Veloxis Pharmaceuticals A since 2017.
He obtained a doctorate degree from the University of Perugia.
Ulf Meier-Kriesche active positions
Companies | Position | Start |
---|---|---|
VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | 2017-09-12 |
Training of Ulf Meier-Kriesche
University of Perugia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Ulf Meier-Kriesche